Apr 28, 2026
Check out the latest UK Price Watch article in the Generics Bulletin for analysis and insight on March 2026 product launches, the biggest risers, the biggest fallers and the fastest movers…. with market data provided by WaveData. Dave Wallace, editor at Generics...
Apr 16, 2026
Charles Joynson takes a look at the long term changes to the commercial behaviour of Gabapentin Caps 300mg 100 When Gabapentin Caps 300mg 100 were launched way back in December 2003 prices came down from over £40 to less than £10 in just three years. It could have...
Apr 16, 2026
When we look at the graph showing the number of concessions granted each month it does appear to have a series of concession cycles, with the first one starting in 2017, the second in 2022 and the third starting at the end of 2025. Therefore, we thought we’d compare...
Mar 9, 2026
Here at WaveData we keep a close eye on the number of concessions granted to individual products each month and have been doing so since they were launched in November 2010. We have always assumed the Category M is the primary source of concessions and of the linked...
Mar 5, 2026
There has been a lot of discussion about Category H at recent events, online and on socials. Charles Joynson, WaveData MD, poses the question; ‘Will it cut another group of generics to the bone and seriously damage pharmacy and supplier profitability? Or will it...
Feb 13, 2026
Charles Joynson, WaveData MD, was delighted to join Jeremy Durrant, Director of Communications and External Engagement at Medicines UK, in the latest episode of their podcast Medicine Matters. It’s a lively discussion, looking at pricing trends over the last 12...
